379 related articles for article (PubMed ID: 14966190)
21. The intracellular transport of MHC class II molecules in the absence of HLA-DM.
Green JM; DeMars R; Xu X; Pierce SK
J Immunol; 1995 Oct; 155(8):3759-68. PubMed ID: 7561080
[TBL] [Abstract][Full Text] [Related]
22. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers.
Hmama Z; Gabathuler R; Jefferies WA; de Jong G; Reiner NE
J Immunol; 1998 Nov; 161(9):4882-93. PubMed ID: 9794422
[TBL] [Abstract][Full Text] [Related]
23. Isolation and characterization of the intracellular MHC class II compartment.
Tulp A; Verwoerd D; Dobberstein B; Ploegh HL; Pieters J
Nature; 1994 May; 369(6476):120-6. PubMed ID: 8177317
[TBL] [Abstract][Full Text] [Related]
24. DR/CLIP (class II-associated invariant chain peptides) and DR/peptide complexes colocalize in prelysosomes in human B lymphoblastoid cells.
Stang E; Guerra CB; Amaya M; Paterson Y; Bakke O; Mellins ED
J Immunol; 1998 May; 160(10):4696-707. PubMed ID: 9590215
[TBL] [Abstract][Full Text] [Related]
25. Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function.
Germain RN
Semin Immunol; 1995 Dec; 7(6):361-72. PubMed ID: 8775462
[TBL] [Abstract][Full Text] [Related]
26. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes.
Brocke P; Armandola E; Garbi N; Hämmerling GJ
Eur J Immunol; 2003 Feb; 33(2):411-21. PubMed ID: 12645938
[TBL] [Abstract][Full Text] [Related]
27. The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain.
Fineschi B; Sakaguchi K; Appella E; Miller J
J Immunol; 1996 Oct; 157(8):3211-5. PubMed ID: 8871612
[TBL] [Abstract][Full Text] [Related]
28. Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies.
Wiendl H; Lautwein A; Mitsdörffer M; Krause S; Erfurth S; Wienhold W; Morgalla M; Weber E; Overkleeft HS; Lochmüller H; Melms A; Tolosa E; Driessen C
J Neuroimmunol; 2003 May; 138(1-2):132-43. PubMed ID: 12742663
[TBL] [Abstract][Full Text] [Related]
29. Individual cathepsins degrade immune complexes internalized by antigen-presenting cells via Fcgamma receptors.
Driessen C; Lennon-Duménil AM; Ploegh HL
Eur J Immunol; 2001 May; 31(5):1592-601. PubMed ID: 11465117
[TBL] [Abstract][Full Text] [Related]
30. Late events in the intracellular sorting of major histocompatibility complex class II molecules are regulated by the 80-82 segment of the class II beta chain.
Tan LJ; Ceman S; Chervonsky A; Rodriguez-Paris J; Steck TL; Sant AJ
Eur J Immunol; 1997 Jun; 27(6):1479-88. PubMed ID: 9209501
[TBL] [Abstract][Full Text] [Related]
31. Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments.
Castellino F; Germain RN
Immunity; 1995 Jan; 2(1):73-88. PubMed ID: 7600303
[TBL] [Abstract][Full Text] [Related]
32. CD1c molecules broadly survey the endocytic system.
Sugita M; van Der Wel N; Rogers RA; Peters PJ; Brenner MB
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8445-50. PubMed ID: 10890914
[TBL] [Abstract][Full Text] [Related]
33. Characterization of transport of newly assembled, T cell-stimulatory MHC class II-peptide complexes from MHC class II compartments to the cell surface.
Pond L; Watts C
J Immunol; 1997 Jul; 159(2):543-53. PubMed ID: 9218568
[TBL] [Abstract][Full Text] [Related]
34. Targeting signal and subcellular compartments involved in the intracellular trafficking of HLA-DMB.
Copier J; Kleijmeer MJ; Ponnambalam S; Oorschot V; Potter P; Trowsdale J; Kelly A
J Immunol; 1996 Aug; 157(3):1017-27. PubMed ID: 8757605
[TBL] [Abstract][Full Text] [Related]
35. Activity and subcellular distribution of cathepsins in primary human monocytes.
Greiner A; Lautwein A; Overkleeft HS; Weber E; Driessen C
J Leukoc Biol; 2003 Feb; 73(2):235-42. PubMed ID: 12554800
[TBL] [Abstract][Full Text] [Related]
36. Invariant chain retains MHC class II molecules in the endocytic pathway.
Loss GE; Sant AJ
J Immunol; 1993 Apr; 150(8 Pt 1):3187-97. PubMed ID: 8468464
[TBL] [Abstract][Full Text] [Related]
37. Early endosomes are required for major histocompatiblity complex class II transport to peptide-loading compartments.
Brachet V; Péhau-Arnaudet G; Desaymard C; Raposo G; Amigorena S
Mol Biol Cell; 1999 Sep; 10(9):2891-904. PubMed ID: 10473634
[TBL] [Abstract][Full Text] [Related]
38. Cutting edge: signals from the B lymphocyte antigen receptor regulate MHC class II containing late endosomes.
Siemasko K; Eisfelder BJ; Williamson E; Kabak S; Clark MR
J Immunol; 1998 Jun; 160(11):5203-8. PubMed ID: 9605114
[TBL] [Abstract][Full Text] [Related]
39. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.
Watts C
Nat Immunol; 2004 Jul; 5(7):685-92. PubMed ID: 15224094
[TBL] [Abstract][Full Text] [Related]
40. Analysis of subcellular organelles involved in major histocompatibility complex (MHC) class II-restricted antigen presentation by electrophoresis.
Engering A; Lefkovits I; Pieters J
Electrophoresis; 1997 Dec; 18(14):2523-30. PubMed ID: 9527480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
